Distribution of serum total homocysteine and its association with diabetes and cardiovascular risk factors of the insulin resistance syndrome in Mexican American men: The Third National Health and Nutrition Examination Survey

Nutrition Journal

Volumn 2, Issue , 2003, Pages 1-7

  Gillum, Richard ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; BLOOD LEVEL; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; HEALTH SURVEY; HISPANIC; HUMAN; INSULIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; NUTRITION; POPULATION RESEARCH; REVIEW; RISK FACTOR; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 3042646937     PISSN: 14752891     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2891-2-6     Document Type: Review

References (52)

1. Boushey CJ, Beresford SAA, Omenn GS and Motulsky AG: A quantitative assesment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995, 274:1049-1057.
2. Hankey GJ and Eikelboom JW: Homocysteine and vascular disease. Lancet 1999, 354:407-413.
3. Eikelboom JW, Lonn E, Genest J Jr, Hankey G and Yusuf S: Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999, 131:363-375.
4. Haffner SM: Progress in population analyses of the insulin resistance syndrome. Ann NY Acad Sci 1997, 827:1-12.
5. Fagan TC and Deedwania PC: The cardiovascular dysmetabolic syndrome. Am J Med 1998, 105:77S-82S.
6. Liese AD, Mayer-Davis EJ and Haffner SM: Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiologic Reviews 1998, 20:157-172.
7. Munshi MN, Stone A, Fink I and Fonseca V: Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease. Metabolism 1996, 45:133-135.
8. Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Fiehn W, Ziegler R, Wahl P and Nawroth PP: Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care 1997, 20:1880-1886.
9. Giles WH, Croft JB, Greenlund KJ, Ford ES and Kittner SJ: Total homocyst(e)ine concentration and the likelihood of nonfatal stroke. Results from the third National Health and Nutrition Examination Survey, 1988-1994. Stroke 1998, 29:2473-2477.
10. Araki A, Sako Y and Ito H: Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment. Atherosclerosis 1993, 103:149-157.
11. Chico A, Perez A, Cordoba A, Arcclus R, Carreras G, de Leiva A, Gonzalez-Sastre F and Blanco-Vaca F: Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia 1998, 41:684-693.
12. Giltay EJ, Hoogeveen EK, Elbers JMH, Gooren LJG, Asscheman H and Stehouwer CDA: Insulin resistance is associated with elevated plasma total homocysteine levels in health, non-obese subjects. Atherosclerosis 1998, 139:197-198.
13. Abbasi F, Facchini F, Humphreys MH and Reaven GM: Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal. Atherosclerosis 1999, 146:175-178.
14. Bar-On H, Kidron M, Friedlander Y, Ben-Yehuda A, Selhub J, Rosenberg IH and Friedman G: Plasma total homocysteine levels in subjects with hyperinsulinemia. J Intern Med 2000, 247:287-294.
15. Reaven GM, Lithell H and Landsberg L: Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996, 334:374-381.
16. Pawson IG, Martorell R and Mendoza FE: Prevalence of overweight and obesity in US Hispanic populations. Am J Clin Nutr 1991:1522S-8S.
17. Stern MP and Mitchell BD: Diabetes in Hispanic Americans. In Diabetes in America 2nd edition. Edited by: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH. Bethesda, Md, National Institutes of Health; 1995:631-659.
18. Giles WH, Croft JB, Greenlund KJ, Ford ES and Kittner JS: Association between total homocyst(e)ine and the likelihood for a history of acute myocardial infarction by race and ethnicity: results from the Third National Health and Nutrition Examination Survey. Am Heart J 2000, 139:446-453.
19. Morris MS, Jacques PF, Selhub J and Rosenberg IH: Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2000, 152:140-148.
20. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. National Center for Health Statistics. Vital Health Stat 1994, 1(32):27.
21. Vargas CM, Burt Vicki L and Gillum RF: Cardiovascular disease in the NHANES III. Ann Epidemiology 1997, 7:523-525.
22. Gunter EW, Lewis BG and Koncikowski SM: Laboratory procedures use for the Third National Health and Nutrition Examination Survey, 1988-94 [CD ROM]. National Center for Health Statistics 1996.
23. Wright JW, Bialostosky K, Gunter EW, Carroll MD, Najjar MF, Bowman BA and Johnson CL: Blood folate and vitamin B12: United States, 1988-94. National Center for Health Statistics, Vital Health Stat 1998, 11(243).
24. Araki A and Sako Y: Determination of free and total homocysteine in human plasma by HPLC with fluorescence detection. J Chromatogr 1987, 422:43-52.
25. Jacques PF, Rosenberg IH, Rogers G, Selhub J, Bowman BA, Gunter EW, Wright JD and Johnson CL: Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 1999, 69:482-489.
26. Harris MI, Eastman RC, Cowie CC, Flegal KM and Eberhardt MS: Racial and ethnic differences in glycemic control of adults with Type 2 diabetes. Diabetes Care 1999, 22:403-408.
27. Westat Inc: National Health and Nutrition Examination Survey III. Body Measurements (Anthropometry). National Center for Health Statistics. 1996.
28. Flegal KM, Carroll MD, Kuczmarski RJ and Johnson CL: Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998, 22:39-47.
29. SAS Institute Inc: SAS Procedures Guide: statistics, version 6 edition. Cary NC: SAS Institute Inc 1990:212-55839.
30. National Center for Health Statistics, Landis JR, Lepkowski JM, Eklund SA and Stehouwer SA: A statistical methodology for analyzing data from a complex survey, the First National Health and Nutrition Examination Survey. Vital and Health Statistics. Series 2, No.92. DHHS Pub. No. (PHS) 82-1366. Public Health Service. Washington. U.S. Government Printing Office 1982.
31. Shah BV, Barnwell BG and Bieler GS: SUDAAN Software for the Statistical Analysis of Correlated Data User's Manual Release 7.0. Research Triangle Park, North Carolina: Research Triangle Institute 1996.
32. Finkelstein JD: The regulation of homocysteine metabolism. In Homocysteine metabolism: from basic science to clinical medicine Edited by: Graham I, Refsum H, Rosenberg IH, Ueland PM, Shuman JM. Boston, Kluwer Academic Publishers; 1997:3-10.
33. Hultberg B, Agardh E, Andersson A, Brattstrom L, Isaksson A, Isreaelsson B and Agardh CD: Increased levels of plasma homocysteine associated with nephropathy, but not severe retinopathy in type I diabetes mellitus. Scand J Clin Lab Invest 1991, 51:277-282.
34. Fonseca VA, Mudaliar S, Schmidt B, Fink LM, Kern PA and Henry RR: Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic by not type 2 diabetic subjects. Metabolism 1998, 47:686-689.
35. Anderson RA: Contributing factors to insulin resistance. Role of dietary factors: micronutrients. Nutr Reviews 2000, 58(11):S10-S11.
36. Smulders YM, Rakic M, Slaats EH, Treskes M, Sijbrands EJ, Odekerken DA, Stehouwer CD and Silberbussch J: Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care 1999, 21:125-132.
37. Hanefeld M: The metabolic syndrome: roots, myths, and facts. In The metabolic syndrome Edited by: Hanefeld M, Leonhardt W. Jena, Gustav Fischer; 1997:13-24.
38. Lempiainen P, Mykkanen L, Pyorala K, Laakso M and Kuusisto J: Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 1999, 100:123-128.
39. Flier JS: An overview of insulin resistance. In Insulin resistance Edited by: Moller DE. Chichester, John Wiley & Sons; 1993:1-8.
40. Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, Wright JD and Johnson CL: Serum total homocysteine concentrations in the Third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999, 131:331-339.
41. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland PM and Kvale G: Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study. JAMA 1995, 274:1526-1533.
42. Hultberg B, Andersson A and Arnadottir M: Plasma homocysteine in renal failure, diabetes mellitus, and alcoholism. In Homocysteine metabolism: from basic science to clinical medicine Edited by: Graham I, Refsum H, Rosenberg IH, Ueland PM, Shuman JM. Boston, Kluwer Academic Publishers; 1997:137-144.
43. Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJC, Jakobs C, Bouter LM, Heine RJ and Stehouwer CDA: Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 1998, 18:133-138.
44. Laivuori H, Kaaja R, Turpeinen U, Viinikka L and Ylikorkala O: Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia. Obstet Gynecol 1999, 93:489-493.
45. Mohadjer L, Bell B and Waksberg J: National Health and Nutrition Examination Survey III. Accounting for item nonresponse bias. Rockville, MD, WESTAT, Inc 1996.
46. Cooper MJ and Zlotkin SH: Day-to-day variation of transferrin receptor and ferritin in healthy men and women. Am J Clin Nutr 1996, 64:738-742.
47. Stout RW: Insulin resistance, hyperinsulinemia, dyslipidemia and atherosclerosis. In Insulin resistance Edited by: Moller DE. Chichester, John Wiley & Sons; 1993:355-384.
48. Appel LJ, Miller ER III, Jee SH, Stolzenberg-Solomon R, Lin P, Erlinger T, Nadeau MR and Selhub J: Effect of dietary patterns on serum homocysteine: results of a randomized, controlled feeding study. Circulation 2000, 102:852-857.
49. Janka HU: Metabolic syndrome and type II diabetes. In The metabolic syndrome Edited by: Hanefeld M, Leonhardt W. Jena, Gustav Fischer; 1997:62-69.
50. Docherty K and Steiner DF: Molecular and cellular biology of the beta cell. In Ellenberg and Rifkin's Diabetes Mellitus 5th edition. Edited by: Porte D Jr, Sherwin RS. Stamford, Connecticut, Appleton Lange; 1997:29-48.
51. Reaven GM: The pathophysiological consequences of adipose tissue insulin resistance. In Insulin resistance: the metabolic syndrome X Edited by: Reaven GM, Laws A. Totowa, New Jersey, Human Press; 1999:233-246.
52. Laws A: Insulin resistance and dyslipidemia: implications for coronary heart disease risk. In Insulin resistance: the metabolic syndrome X Edited by: Reaven GM, Laws A. Totowa, New Jersey, Human Press; 1999:267-280.